Loading...
XTSX
EBM
Market cap48mUSD
Dec 05, Last price  
0.97CAD
1D
-3.00%
1Q
122.99%
IPO
-61.20%
Name

Eastwood Bio-Medical Canada Inc

Chart & Performance

D1W1MN
XTSX:EBM chart
P/E
P/S
76.99
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
3.13%
Revenues
868k
-33.22%
580,321461,5111,186,098463,933479,729743,9731,292,894718,336981,0511,299,763867,936
Net income
-547k
L+240.38%
-139,282-519,098-260,381-468,479-489,624-861,977-579,677-860,030-611,336-160,584-546,598
CFO
-17k
L+293.29%
-252,8841,577,699-270,508-306,577-355,279-454,790-178,129-542,694-116,214-4,294-16,888

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
IPO date
Sep 05, 2014
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT